Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe
Go back to Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe| (NASDAQ: MNPR) | Delayed: 71.84 +1.30 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $70.54 | 52 Week High | $ | |||
| Open | $72.00 | 52 Week Low | $ | |||
| Day High | $73.99 | P/E | N/A | |||
| Day Low | $70.20 | EPS | $ | |||
| Volume | 135,924 | |||||



